These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Therapeutic Strategies for Spinocerebellar Ataxia Type 1. Kerkhof LMC, van de Warrenburg BPC, van Roon-Mom WMC, Buijsen RAM. Biomolecules; 2023 May 02; 13(5):. PubMed ID: 37238658 [Abstract] [Full Text] [Related]
24. Glial S100B protein modulates mutant ataxin-1 aggregation and toxicity: TRTK12 peptide, a potential candidate for SCA1 therapy. Vig PJ, Hearst S, Shao Q, Lopez ME, Murphy HA, Safaya E. Cerebellum; 2011 Jun 02; 10(2):254-66. PubMed ID: 21384195 [Abstract] [Full Text] [Related]
25. Spinocerebellar Ataxia Type 1 protein Ataxin-1 is signaled to DNA damage by ataxia-telangiectasia mutated kinase. Suart CE, Perez AM, Al-Ramahi I, Maiuri T, Botas J, Truant R. Hum Mol Genet; 2021 May 17; 30(8):706-715. PubMed ID: 33772540 [Abstract] [Full Text] [Related]
31. RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1. Park J, Al-Ramahi I, Tan Q, Mollema N, Diaz-Garcia JR, Gallego-Flores T, Lu HC, Lagalwar S, Duvick L, Kang H, Lee Y, Jafar-Nejad P, Sayegh LS, Richman R, Liu X, Gao Y, Shaw CA, Arthur JSC, Orr HT, Westbrook TF, Botas J, Zoghbi HY. Nature; 2013 Jun 20; 498(7454):325-331. PubMed ID: 23719381 [Abstract] [Full Text] [Related]
34. Systems biology analysis of Drosophila in vivo screen data elucidates core networks for DNA damage repair in SCA1. Barclay SS, Tamura T, Ito H, Fujita K, Tagawa K, Shimamura T, Katsuta A, Shiwaku H, Sone M, Imoto S, Miyano S, Okazawa H. Hum Mol Genet; 2014 Mar 01; 23(5):1345-64. PubMed ID: 24179173 [Abstract] [Full Text] [Related]
38. Inhibition of colony-stimulating factor 1 receptor early in disease ameliorates motor deficits in SCA1 mice. Qu W, Johnson A, Kim JH, Lukowicz A, Svedberg D, Cvetanovic M. J Neuroinflammation; 2017 May 25; 14(1):107. PubMed ID: 28545543 [Abstract] [Full Text] [Related]